Search Results - "Cilli, Michele"
-
1
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β
Published in Nature communications (29-04-2019)“…Long noncoding RNAs (lncRNAs) are emerging as regulators of fundamental biological processes. Here we report on the characterization of an intergenic lncRNA…”
Get full text
Journal Article -
2
Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model
Published in Biomaterials (01-05-2011)“…Abstract Most urgent health problems are related to a blood vessel formation failure. The use of stem cells from different sources or species for both in vitro…”
Get full text
Journal Article -
3
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
Published in Oncoimmunology (02-01-2018)“…GD2-redirected chimeric antigen receptor (CAR) T lymphocytes represent a promising therapeutic option for immunotherapy of neuroblastoma (NB). However, despite…”
Get full text
Journal Article -
4
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
Published in Cell cycle (Georgetown, Tex.) (15-11-2013)“…Emerging evidence suggests that metformin, a widely used anti-diabetic drug, may be useful in the prevention and treatment of different cancers. In the present…”
Get full text
Journal Article -
5
Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors
Published in PloS one (15-09-2020)“…Procedures To preliminary assess the relationship between Manganese Enhanced Magnetic Resonance Imaging (MEMRI) and the expression of calcium receptors in…”
Get full text
Journal Article -
6
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
Published in Molecular cancer therapeutics (01-07-2018)“…Novel druggable targets have been discovered in neuroblastoma (NB), paving the way for more effective treatments. However, children with high-risk NB still…”
Get full text
Journal Article -
7
Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS)
Published in PloS one (15-03-2012)“…Bone is a complex dynamic tissue undergoing a continuous remodeling process. Gravity is a physical force playing a role in the remodeling and contributing to…”
Get full text
Journal Article -
8
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
Published in Journal of controlled release (10-08-2015)“…Neuroblastoma is a childhood cancer with poor long-term prognosis in advanced stages. A major aim in neuroblastoma therapy is to develop targeted drug delivery…”
Get full text
Journal Article -
9
Oct 4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
Published in Cell research (01-10-2011)“…Neuroblastoma (NB)-associated endothelial microvesseis (EMs) may be lined by tumor-derived endothelial cells (TECs), that are genetically unstable and…”
Get full text
Journal Article -
10
Enhancement of Tumor Homing by Chemotherapy‐Loaded Nanoparticles
Published in Small (Weinheim an der Bergstrasse, Germany) (01-11-2018)“…Targeted delivery of anticancer drugs with nanocarriers can reduce side effects and ameliorate therapeutic efficacy. However, poorly perfused and dysfunctional…”
Get full text
Journal Article -
11
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Published in Journal of experimental & clinical cancer research (02-06-2021)“…Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and…”
Get full text
Journal Article -
12
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature- specific ligands potentiates therapeutic efficacy
Published in Cancer research (Chicago, Ill.) (15-10-2006)“…Neuroblastoma, the most common solid tumor of infancy derived from the sympathetic nervous system, continues to present a formidable clinical challenge…”
Get full text
Journal Article -
13
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Published in Journal of experimental & clinical cancer research (17-11-2022)“…Abstract Background Poor infiltration of functioning T cells renders tumors unresponsive to checkpoint-blocking immunotherapies. Here, we identified a…”
Get full text
Journal Article -
14
Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation
Published in Scientific reports (17-07-2015)“…Cystic fibrosis (CF) is caused by mutations in the CFTR chloride channel. Deletion of phenylalanine 508 (F508del), the most frequent CF mutation, impairs CFTR…”
Get full text
Journal Article -
15
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
Published in Journal of controlled release (28-09-2013)“…Neuroblastoma is an embryonal tumor originating from the simpatico-adrenal lineage of the neural crest. It approximately accounts for about 15% of all…”
Get full text
Journal Article -
16
Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor
Published in Clinical cancer research (01-10-2010)“…Treatment of neuroblastoma is successful in less than half of patients with high-risk disease. The antitumor activity of a water soluble pegylated SN38 drug…”
Get full text
Journal Article -
17
The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients
Published in Cancer research (Chicago, Ill.) (15-10-2015)“…Neuronal pentraxins (NPTX) and their corresponding receptors (NPTXR) have been studied as synapse-associated proteins in the nervous system, but their role in…”
Get full text
Journal Article -
18
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
Published in Journal for immunotherapy of cancer (01-09-2023)“…Introduction B7-H3 is a potential target for pediatric cancers, including neuroblastoma (NB). Vobramitamab duocarmazine (also referred to as MGC018 and herein…”
Get full text
Journal Article -
19
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression
Published in PloS one (13-01-2012)“…Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at…”
Get full text
Journal Article -
20
Therapeutic Potential of Proteasome Inhibition in Duchenne and Becker Muscular Dystrophies
Published in The American journal of pathology (01-04-2010)“…Duchenne muscular dystrophy (DMD) and its milder allelic variant, Becker muscular dystrophy (BMD), result from mutations of the dystrophin gene and lead to…”
Get full text
Journal Article